FDA Inspection 1002842 — Lucile Salter Packard Children's Hospital Stanford Medicine Fertility And Reproductive Health

Lucile Salter Packard Children's Hospital Stanford Medicine Fertility And Reproductive Health — FEI 3003971418

The FDA completed an inspection of Lucile Salter Packard Children's Hospital Stanford Medicine Fertility And Reproductive Health on Feb 28, 2017 in Sunnyvale, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Feb 28, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Sunnyvale, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.